• SENSEX 82,500.47
    -689.81 (--0.83%)
  • BANKNIFTY 56,754.70
    -201.30 (--0.35%)
  • Enviro Infra
    284.00 392.00(%)
  • Mamata Machinery
    525.00 649.00(%)
  • Glenmark Pharma.
    2,286.15 2,286.15(%)
  • Crizac
    364.00 364.00(%)
  • TCS
    3,261.35 3,060.25(%)
  • Eternal Ltd
    264.90 304.50(%)
  • Hind. Unilever
    2,530.00 3,034.50(%)
  • JP Power Ven.
    24.86 24.86(%)
  • Indian Renewable
    159.05 137.00(%)
  • Tata Elxsi
    5,679.00 4,601.05(%)
  • Infosys
    1,563.25 1,307.10(%)
  • Netweb Technol.
    1,989.00 3,060.00(%)
  • Reliance Industr
    1,490.10 1,115.55(%)
  • RattanIndia Pow.
    15.90 8.44(%)
  • Meta Infotech
    236.25 236.25(%)
  • Interglobe Aviat
    5,937.00 6,019.20(%)
  • Quality Power El
    760.90 270.60(%)
  • Bharat Electron
    404.95 240.15(%)
  • ICICI Bank
    1,414.55 1,153.30(%)
  • Kirloskar Oil
    895.60 544.15(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Makers Laboratories Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 366.0
  • ISIN : INE987A01010
153.20 -1 (-0.87%)
  • As on 11 Jul 2025 (EOD)

  • Today’s Low

    150.55

  • Today’s High

    154.55

  • Open

    154.55

  • Perv Close

    154.55

  • 52W Low

    122.00

  • 52W High

    230.00

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    90.39

  • Div & Yield %

    0.00

  • Book Value(₹)

    95.04

  • Debt-Equity Ratio

    -0.87

  • AGM Date

    11-Jul-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.29

  • Mar.Cap (₹Cr.)

    90.39

  • RONW (%)

    -7.27

  • ROCE (%)

    -2.19

Score Board

  • Equity (₹ in Cr.)

    5.90

  • BV (₹)

    95.00

  • Sales( ₹ in Cr.)

    42.94

  • NP (in Cr.)

    -5.17

  • NP Var(%)

    26.0

  • Div%

    0.0

  • CPS (₹)

    -3.90

  • EPS (₹)

    -8.80

  • Traded Value (₹ in Lakhs)

    90.39

  • 52 Week High

    230.00

  • 52 Week Low

    122.00

  • Price BSE

    153.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    90.39

  • P/C Ratio

    -38.80

  • P/E Ratio

    -17.40

  • Price Vs.BV

    -8.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 42.94 49.09 42.55 52.38 44.41 51.40
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.09
Net Sales 42.94 49.09 42.55 52.38 44.41 51.31
Other Income 10.92 1.15 1.14 0.85 0.41 0.23
Stock Adjustments -3.93 3.06 -4.01 1.52 0.21 -0.70
Total Income 49.93 53.30 39.68 54.75 45.03 50.84
EXPENDITURE :            
Raw Materials 19.41 32.74 23.28 29.44 22.67 28.81
Power and Fuel Cost 4.29 4.90 3.85 3.46 3.00 1.69
Employee Cost 9.05 9.17 7.45 8.16 7.63 7.84
Other Manufacturing Expenses 2.20 2.66 2.24 2.07 1.89 2.08
Selling and Administration Expenses 5.16 5.42 4.71 6.55 5.36 6.17
Miscellaneous Expenses 1.11 1.02 1.13 1.15 0.76 1.29
Employee Benefit Expenses 9.05 9.17 7.45 8.16 7.63 7.84
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 41.22 55.91 42.66 50.84 41.31 47.89
Operating Profit 8.72 -2.61 -3.00 3.90 3.72 2.94
Interest 0.94 1.63 1.38 1.68 1.60 0.70
Gross Profit 7.78 -4.24 -4.38 2.22 2.12 2.24
Depreciation 2.85 2.71 2.40 1.91 4.20 1.99
Profit Before Tax 4.93 -6.95 -6.78 0.31 -2.08 0.25
Current Tax 0.00 0.00 0.02 0.03 -0.17 0.04
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.29 0.00 -0.43 0.11 -0.29 0.33
Reported Net Profit 4.64 -6.95 -6.36 0.17 -1.62 -0.12
Extraordinary Items 9.82 0.02 0.01 -0.04 0.17 0.00
Adjusted Net Profit -5.18 -6.97 -6.37 0.21 -1.79 -0.12
Adjustment below Net Profit -0.04 0.08 -0.02 0.05 -0.05 -0.17
P & L Balance brought forward 15.99 22.86 29.25 28.66 11.92 12.71
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 -0.36 -18.41 0.49
P & L Balance carried down 20.59 15.99 22.86 29.25 28.66 11.92
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 7.87 -11.78 -10.78 0.35 -3.29 -0.25
Earnings Per Share(Adj)-Unit Curr 7.87 -11.78 -10.78 0.35 -3.16 -0.24
Book Value 95.04 87.19 98.78 102.30 100.92 90.74
Book Value(Adj)-Unit Curr 95.04 87.19 98.78 102.30 96.83 87.06

Shareholding Pattern

  • Promoter Group

    61.27%

  • Public Share Holding

    38.73%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 3,106,990 52.66 3,106,990 5
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 508,366 8.62 508,366 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,615,356 61.27 3,615,356 12
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 100 0.00 100 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 22,797 0.39 22,797 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 22,897 0.39 22,897 2
2] Non Institution
Bodies Corporate 134,649 2.28 133,589 32
Clearing Members 0 0.00 0 0
Directors of their Relatives 29,615 0.50 28,955 2
Employees 100 0.00 0 1
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 34,659 0.59 30,159 58
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 70,987 1.20 70,987 106
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 462,664 7.84 462,664 11
Individuals holding nominal share capital up to Rs. 1 lakh 1,366,848 23.17 1,283,886 3,845
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 162,100 2.75 162,100 2
Sub Total 2,262,123 38.34 2,172,841 4,059
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 5,900,376 100.00 5,811,094 4,073

Company Background

Makers Laboratories LtdPharmaceuticals - Indian - Formulations

  • Makers Laboratories Ltd
  • BSE Code : 366.0
  • ISIN : INE987A01010

  • Incorporation Year

    1984

  • Registered Office

    54 D Kandivli Industrial Estat
    Charkop Kandivli (West), Mumbai,
    Maharashtra-400067

  • Telephone

    91-22-2868 8544

  • FAX

    91-22-2868 8544

  • Chairman

    R K P Verma

  • Managing Director

  • Company Secretary

    Piyush Ajmera

  • Auditor

    Natvarlal Vepari & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Makers Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Makers Labs. 153.20 53.87 42.94 19.47 -6.71
Abbott India 34,409.95 6,097.18 5,848.91 51.70 44.71
Astrazeneca Phar 9,237.05 1,330.33 1,295.53 199.50 33.26
P & G Health Ltd 5,777.05 1,166.89 1,151.26 38.18 39.76
Glaxosmi. Pharma 3,242.30 3,866.05 3,723.49 59.77 58.72
Cipla 1,485.05 20,029.57 19,044.85 23.25 21.40
Amrutanjan Healt 726.25 437.58 421.23 41.31 20.84
Fermenta Biotec. 384.45 315.24 307.09 16.74 4.10
Guj. Themis Bio. 343.55 174.19 169.82 76.69 44.82
Bliss GVS Pharma 153.75 703.42 667.20 23.51 9.16
Ambalal Sarabhai 36.16 19.33 4.04 33.48 2.10